Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
A Polysaccharide-RBD-Fc-Conjugated COVID-19 Vaccine, SCTV01A, Showed High Immunogenicity and Low Toxicity in Animal Models.
Vaccines (Basel). 2023 Feb 23;11(3):526. doi: 10.3390/vaccines11030526.
Vaccines (Basel). 2023.
PMID: 36992109
Free PMC article.
Rational Development of a Polysaccharide-Protein-Conjugated Nanoparticle Vaccine Against SARS-CoV-2 Variants and Streptococcus pneumoniae.
Deng Y, Li J, Sun C, Chi H, Luo D, Wang R, Qiu H, Zhang Y, Wu M, Zhang X, Huang X, Xie L, Qin C.
Deng Y, et al.
Adv Mater. 2022 May;34(21):e2200443. doi: 10.1002/adma.202200443. Epub 2022 Apr 21.
Adv Mater. 2022.
PMID: 35332581
Free PMC article.
Item in Clipboard
Cite
Cite